Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device User Fee Amendments of 2007; Foreign Small Business Qualification Certification, Form FDA 3602A, 19508-19509 [E8-7637]
Download as PDF
19508
Federal Register / Vol. 73, No. 70 / Thursday, April 10, 2008 / Notices
and respond to STD outbreaks and
trends in STD-associated risk behavior.
Users of data include, but are not
limited to, congressional offices, state
and local health agencies, health care
providers, and other health-related
groups.
CDC disseminates all STD
surveillance information through the
MMWR series of publications, including
the MMWR, the CDC Surveillance
Summaries, the Recommendations and
Reports, and the annual Summary of
Notifiable Diseases, United States.
Additionally, DSTDP publishes an
annual STD-specific surveillance
summary and supplements in hard copy
on CD–ROM and on the Internet https://
www.cdc.gov/nchstp/dstd/Stats_
Trends/Stats_and_Trends.htm.
CDC will use the findings from this
and other STD surveillance to develop
guidelines, control strategies, and
impact measures that monitor trends in
STDs in the United States.
We expect a total of 57 sites in state,
city, and territory health departments
will be submitting STD morbidity
information to CDC each week.
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Types of data collection
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
in hours
States ...............................................................................................................
Territories .........................................................................................................
Cities ................................................................................................................
50
5
2
52
52
52
20/60
20/60
20/60
867
87
35
Totals ........................................................................................................
57
........................
........................
989
Dated: April 3, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–7575 Filed 4–9–08; 8:45 am]
should be identified with the OMB
control number 0910–0613. Also
include the FDA docket number found
in brackets in the heading of this
document.
BILLING CODE 4163–18–P
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Denver Presley, Jr., Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1472.
Food and Drug Administration
[Docket No. FDA–2008–N–0027] (formerly
Docket No. 2007N–0495)
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Medical Device
User Fee Amendments of 2007;
Foreign Small Business Qualification
Certification, Form FDA 3602A
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on PROD1PC66 with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by May 12,
2008.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
baguilar@omb.eop.gov. All comments
VerDate Aug<31>2005
16:48 Apr 09, 2008
Jkt 214001
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Medical Device User Fee Amendments
of 2007; Foreign Small Business
Qualification Certification, Form FDA
3602A—(OMB Control Number 0910–
0613)—Extension
The FDA Amendments Act of 2007
includes the ‘‘Medical Device User Fee
Amendments of 2007’’ (the 2007
Amendments), which reauthorizes
medical device user fees for fiscal years
(FY) 2008 through 2012 and which
makes significant changes to the
medical device user fee provisions of
the act. The 2007 Amendments provide
a new way for a foreign business to
qualify as a small business eligible to
pay a significantly lower fee when a
medical device user fee must be paid.
Before passage of the 2007
Amendments, the only way a business
could qualify as a small business was to
submit a Federal (U.S.) income tax
return showing its gross receipts or sales
that did not exceed a statutory
threshold, (currently $100 million). If a
business could not provide a Federal
income tax return, it did not qualify as
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
a small business and had to pay the
standard (full) fee. Because many
foreign businesses have not, and cannot,
file a Federal (U.S.) income tax return,
this requirement has effectively
prevented those businesses from
qualifying for the small business fee
rates. Thus, foreign governments,
including the European Union, have
objected.
In lieu of a Federal income tax return,
the 2007 Amendments will allow a
foreign business to qualify as a small
business by submitting a certification
from its national taxing authority, the
foreign equivalent of our Internal
Revenue Service. This certification,
referred to as a ‘‘National Taxing
Authority Certification,’’ must:
• Be in English;
• Be from the national taxing
authority of the country in which the
business is headquartered;
• Provide the business’ gross receipts
or sales for the most recent year, in both
the local currency and in U.S. dollars,
and the exchange rate used in
converting local currency to U.S.
dollars;
• Provide the dates during which the
reported receipts or sales were
collected; and
• Bear the official seal of the national
taxing authority.
The new FDA Form 3602A, ‘‘FY 2008
MDUFMA Foreign Small Business
Qualification Certification,’’ will collect
the information required by the statute
and allows a foreign business to qualify
for the same small business benefits as
a domestic U.S. business.
In the Federal Register of January 15,
2008 (73 FR 2503), FDA published a 60day notice requesting public comment
on the information collection
E:\FR\FM\10APN1.SGM
10APN1
19509
Federal Register / Vol. 73, No. 70 / Thursday, April 10, 2008 / Notices
provisions. In response to this notice,
FDA received two general comments on
the information collection requirements
which are described in this document
along with FDA’s responses.
(Comment 1) The commenter
recommended that once a firm has
qualified for small business status, this
should be good enough for 3 to 5 years.
Further, that it would be quite unlikely
that a small business firm would move
from a small business to a huge business
in 3 years, particularly for the starting
business or very small business. The
commenter concluded that the extra
paperwork will cost time and money for
the industry and FDA as well.
(Response) FDA cannot accept this
recommendation, because current
provisions of the 2007 Amendments do
not permit the recommended approach.
Section 738(d)(2)(B) and (e)(2)(B) of the
act (21 U.S.C. 379j(d)(2)(B) and (e)(2)(B))
defines the ‘‘Evidence of Qualification’’
that must be provided to qualify as a
small business. The provisions
specifically require the applicant to
support its claim that it qualifies as a
small business by submitting, among
other things, the following:
• ‘‘a copy of the most recent Federal
income tax return for a taxable year’’
and
• A signed certification of gross
receipts or sales for the most recent
year.
Because both requirements specify
that the information must be for the
‘‘most recent’’ year, FDA cannot
determine whether an applicant’s status
as a small business will persist for a
period of more than 1 year.
(Comment 2) The commenter
expressed concern there could be some
problems in collecting the tax
certification information required of
Form FDA 3602A, Section III, from the
national taxing authority of each
country where an applicant has
business entities. The commenter cited
that in some countries, the national
taxing authority may not agree to fill out
this form for various reasons including:
(1) The fact that it may not be its own
official form, (2) the form is in English,
and (3) authorities do not agree to
determine the exchange rate for the U.S.
dollar.
As an alternative to Form FDA 3602A,
Section III, the commenter recommends
the following information be provided:
• A tax report or an income statement
from each country of business entities,
• Translation to English could be
organized by the applicant, and a
• Determination of exchange rate
could be done by the applicant.
(Response) FDA cannot accept this
recommendation because the agency
does not have authority to modify the
statutory requirement for a signed
certification form, and bearing the seal
of the national taxing authority of the
country in which the applicant, or if
applicable, affiliate, is headquartered
(see section 738(d)(2)(B)(iii) and
738(e)(2)(B)(iii)).
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
Form FDA 3602A
Annual Frequency
per Response
Total Annual
Responses
Hours per
Response
Total Hours
Sections I and II (completed by
the business seeking small
business status)
229
1
229
1
229
Section III (completed by the foreign national taxing authority)
33
7
231
1
231
Total
mstockstill on PROD1PC66 with NOTICES
1There
460
are no capital costs or operating and maintenance costs associated with this collection of information.
This burden estimate is based on an
examination of 510(k) premarket
notifications received during FY 2006
and FDA’s estimation of the time to
collect the required information to
complete Form FDA 3602A. The
evidence supporting each Form FDA
3602A must be reviewed by a foreign
national taxing authority to complete
Section III, the National Taxing
Authority Certification, of each Form
FDA 3602A. Because this is a new
activity, and neither FDA nor any
foreign national taxing authority has any
data that would provide an objective
measure of the effort required to
complete Section III, FDA is estimating
that the burden will be the same as FDA
experiences in reviewing Form FDA
3602, ‘‘FY 2008 MDUFMA Small
Business Qualification Certification For
a Business Headquartered in the United
States,’’ approved under OMB control
number 0910–0508.
FDA believes most entities that
submit Form FDA 3602A will not have
any affiliates, and very few will have
VerDate Aug<31>2005
16:48 Apr 09, 2008
Jkt 214001
more than three or four affiliates. Based
on our experience with FDA Form 3602,
FDA believes each business will require
1 hour to complete Sections I and II.
Because this is a new requirement, FDA
does not have any data on the time that
will be required to complete Section III,
the National Taxing Authority
Certification.
Dated: April 7, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–7637 Filed 4–9–08; 8:45 am]
Food and Drug Administration
[Docket No. FDA–2008–N–0213] (formerly
Docket No. 2007N–0460)
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Reports of
Corrections and Removals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
BILLING CODE 4160–01–S
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by May 12,
2008.
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\10APN1.SGM
10APN1
Agencies
[Federal Register Volume 73, Number 70 (Thursday, April 10, 2008)]
[Notices]
[Pages 19508-19509]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-7637]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0027] (formerly Docket No. 2007N-0495)
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Medical Device User
Fee Amendments of 2007; Foreign Small Business Qualification
Certification, Form FDA 3602A
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by May 12,
2008.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-6974, or e-mailed to baguilar@omb.eop.gov. All comments
should be identified with the OMB control number 0910-0613. Also
include the FDA docket number found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of the
Chief Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-1472.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Medical Device User Fee Amendments of 2007; Foreign Small Business
Qualification Certification, Form FDA 3602A--(OMB Control Number 0910-
0613)--Extension
The FDA Amendments Act of 2007 includes the ``Medical Device User
Fee Amendments of 2007'' (the 2007 Amendments), which reauthorizes
medical device user fees for fiscal years (FY) 2008 through 2012 and
which makes significant changes to the medical device user fee
provisions of the act. The 2007 Amendments provide a new way for a
foreign business to qualify as a small business eligible to pay a
significantly lower fee when a medical device user fee must be paid.
Before passage of the 2007 Amendments, the only way a business
could qualify as a small business was to submit a Federal (U.S.) income
tax return showing its gross receipts or sales that did not exceed a
statutory threshold, (currently $100 million). If a business could not
provide a Federal income tax return, it did not qualify as a small
business and had to pay the standard (full) fee. Because many foreign
businesses have not, and cannot, file a Federal (U.S.) income tax
return, this requirement has effectively prevented those businesses
from qualifying for the small business fee rates. Thus, foreign
governments, including the European Union, have objected.
In lieu of a Federal income tax return, the 2007 Amendments will
allow a foreign business to qualify as a small business by submitting a
certification from its national taxing authority, the foreign
equivalent of our Internal Revenue Service. This certification,
referred to as a ``National Taxing Authority Certification,'' must:
Be in English;
Be from the national taxing authority of the country in
which the business is headquartered;
Provide the business' gross receipts or sales for the most
recent year, in both the local currency and in U.S. dollars, and the
exchange rate used in converting local currency to U.S. dollars;
Provide the dates during which the reported receipts or
sales were collected; and
Bear the official seal of the national taxing authority.
The new FDA Form 3602A, ``FY 2008 MDUFMA Foreign Small Business
Qualification Certification,'' will collect the information required by
the statute and allows a foreign business to qualify for the same small
business benefits as a domestic U.S. business.
In the Federal Register of January 15, 2008 (73 FR 2503), FDA
published a 60-day notice requesting public comment on the information
collection
[[Page 19509]]
provisions. In response to this notice, FDA received two general
comments on the information collection requirements which are described
in this document along with FDA's responses.
(Comment 1) The commenter recommended that once a firm has
qualified for small business status, this should be good enough for 3
to 5 years. Further, that it would be quite unlikely that a small
business firm would move from a small business to a huge business in 3
years, particularly for the starting business or very small business.
The commenter concluded that the extra paperwork will cost time and
money for the industry and FDA as well.
(Response) FDA cannot accept this recommendation, because current
provisions of the 2007 Amendments do not permit the recommended
approach. Section 738(d)(2)(B) and (e)(2)(B) of the act (21 U.S.C.
379j(d)(2)(B) and (e)(2)(B)) defines the ``Evidence of Qualification''
that must be provided to qualify as a small business. The provisions
specifically require the applicant to support its claim that it
qualifies as a small business by submitting, among other things, the
following:
``a copy of the most recent Federal income tax return for
a taxable year'' and
A signed certification of gross receipts or sales for the
most recent year.
Because both requirements specify that the information must be for
the ``most recent'' year, FDA cannot determine whether an applicant's
status as a small business will persist for a period of more than 1
year.
(Comment 2) The commenter expressed concern there could be some
problems in collecting the tax certification information required of
Form FDA 3602A, Section III, from the national taxing authority of each
country where an applicant has business entities. The commenter cited
that in some countries, the national taxing authority may not agree to
fill out this form for various reasons including: (1) The fact that it
may not be its own official form, (2) the form is in English, and (3)
authorities do not agree to determine the exchange rate for the U.S.
dollar.
As an alternative to Form FDA 3602A, Section III, the commenter
recommends the following information be provided:
A tax report or an income statement from each country of
business entities,
Translation to English could be organized by the
applicant, and a
Determination of exchange rate could be done by the
applicant.
(Response) FDA cannot accept this recommendation because the agency
does not have authority to modify the statutory requirement for a
signed certification form, and bearing the seal of the national taxing
authority of the country in which the applicant, or if applicable,
affiliate, is headquartered (see section 738(d)(2)(B)(iii) and
738(e)(2)(B)(iii)).
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual Hours per
Form FDA 3602A Respondents per Response Responses Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Sections I and II (completed by the business seeking 229 1 229 1 229
small business status)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Section III (completed by the foreign national taxing 33 7 231 1 231
authority)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total 460
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
This burden estimate is based on an examination of 510(k) premarket
notifications received during FY 2006 and FDA's estimation of the time
to collect the required information to complete Form FDA 3602A. The
evidence supporting each Form FDA 3602A must be reviewed by a foreign
national taxing authority to complete Section III, the National Taxing
Authority Certification, of each Form FDA 3602A. Because this is a new
activity, and neither FDA nor any foreign national taxing authority has
any data that would provide an objective measure of the effort required
to complete Section III, FDA is estimating that the burden will be the
same as FDA experiences in reviewing Form FDA 3602, ``FY 2008 MDUFMA
Small Business Qualification Certification For a Business Headquartered
in the United States,'' approved under OMB control number 0910-0508.
FDA believes most entities that submit Form FDA 3602A will not have
any affiliates, and very few will have more than three or four
affiliates. Based on our experience with FDA Form 3602, FDA believes
each business will require 1 hour to complete Sections I and II.
Because this is a new requirement, FDA does not have any data on the
time that will be required to complete Section III, the National Taxing
Authority Certification.
Dated: April 7, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-7637 Filed 4-9-08; 8:45 am]
BILLING CODE 4160-01-S